News

Novo Nordisk: Nothing Has Changed, Except That It's Cheaper Now
Novo Nordisk's competitive position is strengthening, driven by strong sales growth in Wegovy, Ozempic, and rare diseases.
CEO of company that created Ozempic and Wegovy addressed 'long-term' impacts of the drug
Lars Fruergaard Jørgensen, the boss of Danish pharmaceutical giant Novo Nordisk, explained what impact the drugs can have on users weight in the long run ...
Novo Nordisk Cuts Guidance as Copycat Versions of Ozempic Hit Sales
Alternative compounded versions of Novo Nordisk’s blockbuster weight-loss and diabetes drugs have hurt its sales, ...
A New Wave of Lawsuits Alleges Ozempic Causes Patients to Go Blind
About a dozen lawsuits, citing 2024 studies, allege Ozempic causes a rare eye disorder that leads to irreversible blindness. ...
All the surprisingly positive side effects of Ozempic and similar jabs apart from appetite suppression
Despite Ozempic being the most recognisable brand name, as far as the people prescribing it are concerned weight loss is ...
Forget Ozempic face – should we be worried about Ozempic teeth?
With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention. Helen Coffey speaks to the dentists warning that jabs could have a worrying im ...
Novo Nordisk Q1 2025: One Of The Best Deals You Can Get Right Now
Novo Nordisk's Q1 2025 results show a 19% sales increase, 20% operating income growth, and 14% net profit rise. Read why NVO ...
Maryland Daily Record13dOpinion
MD man sues Novo Nordisk, alleging Ozempic made him blind
A Howard County man is suing Novo Nordisk, alleging Ozempic caused him to go blind after using the drug to treat diabetes.
Ozempic, Wegovy took my vision, says grandma of 11 and NJ man — as more users report ‘devastating’ side effect
A grandma of 11 and a New Jersey man have joined the growing chorus of users of the wildly popular weight-loss drugs Ozempic ...
‘There's a huge percentage of the US population that isn't getting access to these medications’: Novo Nordisk makes game-changing $2 billion deal for new obesity d…
Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...